Somatrogon

( DrugBank: Somatrogon / KEGG DRUG: Somatrogon )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
78	下垂体前葉機能低下症	15

78. 下垂体前葉機能低下症

臨床試験数 : 492 / 薬物数 : 341 - (DrugBank : 47) / 標的遺伝子数 : 45 - 標的パスウェイ数 : 100

trials per page:

Showing 1 to 10 of 15 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05602766 (ClinicalTrials.gov)	February 6, 2023	27/10/2022	Ngenla Subcutaneous Injection Special Investigation	Ngenla® Subcutaneous Injection Special Investigation	Growth Hormone Deficiency Without Epiphyseal Closure	Drug: NGENLA (Somatrogon)	Pfizer	NULL	Recruiting	N/A	15 Years	All	229		Japan
2	EUCTR2018-000918-38-BG (EUCTR)	16/07/2019	23/05/2019	STUDY ASSESSING SUBJECT PERCEPTION OF TREATMENT BURDEN WITH USE OF WEEKLY GROWTH HORMONE (SOMATROGON ...	A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL, CROSSOVER STUDY ASSESSING SUBJECT PERCEPTION OF TREA ...	Growth Hormone Deficiency in Children MedDRA version: 20.0;Level: PT;Classification code 10056438;Te ...	Product Name: Somatrogon Product Code: PF-06836922 INN or Proposed INN: somatrogon Trade Name: Genotrop ...	Pfizer Inc.	NULL	Not Recruiting			Female: yes Male: yes	90	Phase 3	United States;Czech Republic;Slovakia;Bulgaria;United Kingdom
3	EUCTR2018-000918-38-SK (EUCTR)	11/07/2019	11/02/2019	STUDY ASSESSING SUBJECT PERCEPTION OF TREATMENT BURDEN WITH USE OF WEEKLY GROWTH HORMONE (SOMATROGON ...	A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL, CROSSOVER STUDY ASSESSING SUBJECT PERCEPTION OF TREA ...	Growth Hormone Deficiency in Children MedDRA version: 20.0;Level: PT;Classification code 10056438;Te ...	Product Name: Somatrogon Product Code: PF-06836922 INN or Proposed INN: somatrogon Trade Name: Genotrop ...	Pfizer Inc.	NULL	Not Recruiting			Female: yes Male: yes	90	Phase 3	United States;Czech Republic;Slovakia;Bulgaria;United Kingdom
4	EUCTR2018-000918-38-CZ (EUCTR)	27/06/2019	20/03/2019	STUDY ASSESSING SUBJECT PERCEPTION OF TREATMENT BURDEN WITH USE OF WEEKLY GROWTH HORMONE (SOMATROGON ...	A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL, CROSSOVER STUDY ASSESSING SUBJECT PERCEPTION OF TREA ...	Growth Hormone Deficiency in Children MedDRA version: 20.0;Level: PT;Classification code 10056438;Te ...	Product Name: Somatrogon Product Code: PF-06836922 INN or Proposed INN: somatrogon Trade Name: Genotrop ...	Pfizer Inc.	NULL	Not Recruiting			Female: yes Male: yes	90	Phase 3	United States;Czech Republic;Slovakia;Bulgaria;United Kingdom
5	EUCTR2018-000918-38-GB (EUCTR)	16/05/2019	27/11/2018	STUDY ASSESSING SUBJECT PERCEPTION OF TREATMENT BURDEN WITH USE OF WEEKLY GROWTH HORMONE (SOMATROGON ...	A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL, CROSSOVER STUDY ASSESSING SUBJECT PERCEPTION OF TREA ...	Growth Hormone Deficiency in Children MedDRA version: 20.0;Level: PT;Classification code 10056438;Te ...	Product Name: Somatrogon Product Code: PF-06836922 INN or Proposed INN: somatrogon Trade Name: Genotrop ...	Pfizer Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	90	Phase 3	United States;Czech Republic;Slovakia;Bulgaria;United Kingdom
6	NCT03831880 (ClinicalTrials.gov)	February 7, 2019	21/12/2018	Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children ...	A PHASE 3, RANDOMIZED, MULTICENTER, OPEN-LABEL, CROSSOVER STUDY ASSESSING SUBJECT PERCEPTION OF TREA ...	Growth Hormone Deficiency	Drug: Genotropin;Drug: somatrogon	Pfizer	NULL	Completed	3 Years	17 Years	All	87	Phase 3	United States;Bulgaria;Czechia;Slovakia;United Kingdom
7	JPRN-JapicCTI-183963	25/12/2017	17/05/2018	Safety and Efficacy Study of MOD-4023 to Treat Children With Growth Hormone Deficiency	A PHASE 3, OPEN-LABEL, RANDOMIZED, MULTICENTER, 12-MONTH, EFFICACY AND SAFETY STUDY OF WEEKLY MOD-40 ...	Treatment of children with growth failure due to growth hormone deficiency (GHD)	Intervention name : Somatrogon(Genetical Recombination) INN of the intervention : somatrogon Dosage An ...	OPKO Health Inc.(ICCC: EPS International Holdings Co., Ltd)	NULL	complete	3	11	BOTH	44	Phase 3	Japan
8	EUCTR2016-003874-42-GR (EUCTR)	20/12/2017	21/11/2017	An efficacy and safety study of weekly mod-4023 compared to daily genotropin® therapy in pre-puberta ...	A phase 3, open-label, randomized, multicenter, 12 months, efficacy and safety study of weekly mod-4 ...	Growth hormone deficiency in pre-pubertal children MedDRA version: 20.0;Level: PT;Classification cod ...	Product Code: MOD-4023 INN or Proposed INN: Somatrogon Product Code: MOD-4023 INN or Proposed INN: Soma ...	OPKO Biologics Ltd.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	220	Phase 3	United States;Belarus;Taiwan;Greece;Spain;Ukraine;Turkey;Russian Federation;Israel;Colombia;United K ...
9	EUCTR2016-003874-42-GB (EUCTR)	04/09/2017	03/01/2017	An efficacy and safety study of weekly mod-4023 compared to daily genotropin® therapy in pre-puberta ...	A phase 3, open-label, randomized, multicenter, 12 months, efficacy and safety study of weekly mod-4 ...	Growth hormone deficiency in pre-pubertal children MedDRA version: 20.0;Level: PT;Classification cod ...	Product Code: MOD-4023 INN or Proposed INN: Somatrogon Product Code: MOD-4023 INN or Proposed INN: Soma ...	OPKO Biologics Ltd.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	220	Phase 3	Taiwan;Greece;Spain;Ukraine;Turkey;Russian Federation;Israel;Colombia;United Kingdom;India;France;Me ...
10	EUCTR2016-003874-42-DE (EUCTR)	04/08/2017	01/02/2017	An efficacy and safety study of weekly mod-4023 compared to daily genotropin® therapy in pre-puberta ...	A phase 3, open-label, randomized, multicenter, 12 months, efficacy and safety study of weekly mod-4 ...	Growth hormone deficiency in pre-pubertal children MedDRA version: 19.1;Level: PT;Classification cod ...	Product Code: MOD-4023 INN or Proposed INN: Somatrogon Product Code: MOD-4023 INN or Proposed INN: Soma ...	OPKO Biologics Ltd.	NULL	Not Recruiting			Female: yes Male: yes	220	Phase 3	Serbia;Belarus;United States;Taiwan;Greece;Spain;Ukraine;Russian Federation;Chile;Israel;Colombia;It ...

First Previous1 2Next Last